Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Matthew F. Plevak"'
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Every case of breast cancer is unique, and treatment must be personalized to incorporate a woman’s values and preferences. We developed an individually-tailored mobile patient education application for women with breast cancer.
Externí odkaz:
https://doaj.org/article/3474b4e1e3c7465f93f8be8469a3f5ff
Autor:
Bao D. Dao, PharmD, Jason N. Barreto, PharmD, Robert C. Wolf, PharmD, Ross A. Dierkhising, MS, Matthew F. Plevak, BS, Pritish K. Tosh, MD
Publikováno v:
Current Therapeutic Research, Vol 76, Iss C, Pp 104-109 (2014)
Objectives: Trimethoprim (TMP)/sulfamethoxazole (SMX) has consistently demonstrated great interindividual variability. Therapeutic drug monitoring may be used to optimize dosing. Optimal peak SMX concentration has been proposed as 100 to 150 μg/mL.
Externí odkaz:
https://doaj.org/article/b1c8ac5859144a56a0c389aafdf64497
Autor:
Kathleen J. Yost, Christopher R. Roscher, Steven B. Porter, Stephania Paredes, Matthew F. Plevak, J. Ross Renew
Publikováno v:
Anesthesia & Analgesia. 134:269-275
BACKGROUND The pattern of perioperative use of personal electronic devices (PEDs) among anesthesia providers in the United States is unknown. METHODS We developed a 31-question anonymous survey of perioperative PED use that was sent to 813 anesthesio
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 19, Iss 1, Pp 1-11 (2019)
BMC Medical Informatics and Decision Making
BMC Medical Informatics and Decision Making
Background Every case of breast cancer is unique, and treatment must be personalized to incorporate a woman’s values and preferences. We developed an individually-tailored mobile patient education application for women with breast cancer. Methods P
Autor:
Andrew Bentall, Mounika Angirekula, Latonya J. Hickson, Matthew F. Plevak, Lilach O. Lerman, Hui Tang, Manhal Izzy, Ross A. Dierkhising, Kymberly D. Watt
Publikováno v:
Transplant international : official journal of the European Society for Organ Transplantation.
Autor:
Ross A. Dierkhising, Douglas R. Osmon, Jason N. Barreto, Andrew H. Limper, Carrie A. Thompson, Matthew F. Plevak, Lauren L. Ice, Pritish K. Tosh
Publikováno v:
American Journal of Hematology. 91:1113-1117
Recent literature has demonstrated concern over the risk of Pneumocystis jirovecii pneumonia (PJP) when administering rituximab with combination chemotherapy such as in R-CHOP; however, the exact risk and potential need for prophylaxis is unknown. We
Autor:
Sarah Nelson, Maria I. Lapid, Jonathan G. Leung, William V. Bobo, Julie L. Cunningham, Simon Kung, Ross A. Dierkhising, Matthew F. Plevak, Virginia H. Thompson
Publikováno v:
Clinical Pharmacokinetics. 55:971-976
Quetiapine is an oral atypical antipsychotic drug commonly used to treat a large number of neuropsychiatric disorders and conditions. However, a substantial number of patients who may benefit from treatment with quetiapine are unable to ingest quetia
Autor:
Mounika Angirekula, Navine Nasser-Ghodsi, Ross A. Dierkhising, Manhal Izzy, Kymberly D. Watt, Matthew F. Plevak, Amir Lerman
Publikováno v:
Transplantation Direct
Autor:
Ross A. Dierkhising, Erin Frazee, Barry A. Boilson, Sarah Schettle, Scott D Nei, Matthew F. Plevak, Shannon L. Piche, John M. Stulak
Publikováno v:
ASAIO journal (American Society for Artificial Internal Organs : 1992). 65(5)
Left ventricular assist device (LVAD) pump thrombosis occurs in up to 8.4% of patients within 3-months postimplantation. Thromboelastography (TEG) could be used to signal hypercoagulability at LVAD implantation to predict patients at high risk for th
415 External Validation of the Progression in Barrett’s Score in a Prospective Multicenter BE Cohort
Autor:
Don C. Codipilly, Ramona Lansing, Sravanthi Parasa, Matthew F. Plevak, Michele Johnson, Ross A. Dierkhising, Kevin F. Kennedy, Prateek Sharma, Prasad G. Iyer
Publikováno v:
American Journal of Gastroenterology. 114:S244-S244